|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | |
| B82Y 5/00 | |||
| A61K 47/69 | |||
| A61P 35/00 |
| (11) | Number of the document | 2611421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11822698.4 |
| Date of filing the European patent application | 2011-09-02 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/050287 |
| Date | 2011-09-02 |
| (87) | Number | WO 2012/031175 |
| Date | 2012-03-08 |
| (30) | Number | Date | Country code |
| 201113224399 | 2011-09-02 | US | |
| 402686 P | 2010-09-02 | US |
| (72) |
REISFELD, Ralph A., US
XIANG, Rong, US
LUO, Yunping, US
LIAO, Debbie, US
LIU, Ze, CN
CHEN, Tingmei, CN
CHEN, Si, CN
LU, Dan, US
|
| (73) |
The Scripps Research Institute,
10550 North Torrey Pines Road, TPC-9, La Jolla, CA 92037,
US
|
| (54) | NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY |
| NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY |